Alberto Bardelli

基本信息

浏览量：293

职业迁徙

个人简介

Alberto Bardelli, a molecular geneticist and expert in the field of personalized therapies, directs the IFOM Genomics of Cancer and Targeted Therapies program at the Institute for Cancer Research and Treatment in Candiolo, near Turin.
He has authored more than 140 scientific articles of which 100 as an independent investigator. Discoveries from his group led the development of diagnostic tests, currently in clinical use, which are based on the genetic profiles of individual tumors. These discoveries represent the first example of personalized therapies for colorectal cancer patients, as was recently reported by the Bardelli's laboratory in Nature, JAMA, and Lancet Oncology.

研究兴趣

论文共 586 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Phase Ia/b Study of MEK1/2 Inhibitor Binimetinib with MET Inhibitor Crizotinib in Patients with RAS Mutant Advanced Colorectal Cancer (Mercuric)

Francesca Aroldi,Elena Elez,Thierry André,Geraldine Perkins,Hans Prenen,Vlad Popovici, Peter Gallagher, Jennifer Houlden, Linda Collins,Corran Roberts,Christian Rolfo,Federica Di Nicolantonio, Margaret Grayson, Ruth Boyd, Karolien Bettens, Jurgen Delfavero,Victoria Coyle,Mark Lawler,Hajrah Khawaja, Pierre Laurent-Puig, Manuel Salto-Tellez, Tim S. Maughan,Josep Tabernero,Richard Adams,Robert Jones,Bryan T. Hennessy,Alberto Bardelli,Marc Peeters, Mark R. Middleton,Richard H. Wilson,Sandra Van Schaeybroeck

BMC Cancerno. 1 (2025): 1-15

引用0浏览0WOS引用

Induction of a Mismatch Repair Deficient Genotype by Tailored Chemical Mutagenesis in Experimental Models of Cancer

Benoit Rousseau,Mitesh Patel,Oliver Artz, Georgios Vlachos, Shrey Patel, Omar Hayatt, Guillem Argilés, Michael B Foote, Lingqi Luo, Rachna Shah, Shub Mehta, Karthik Rangavajhula, Caitlin-M Stewart, Drew Gerber, Rohini Bhattacharya, Dennis Stephens, David Mieles, Violaine Randrian, Somer Abdelfattah, Lin Zhang, Nathalie Membreno-Berganza, Michelle F Lamendola-Essel, Florence Piastra-Facon,Joana Vidal, Paul Johannet,Steve Lu, James R White,Steven B Maron,Afsar Barlas, Caroline M Weipert, Eric Rosiek, Taotao Zhang, Bing He,Sebastien Monette,Rui Qu, Deborah Fidele, Sydney Bowker, Alec Kahn,Pietro Paolo Vitiello,Giovanni Germano,Alberto Bardelli, Rajarsi Mandal,Xiaoxiao Ma, Tim A Chan, Sydney Lu,Andrea Cercek, Omar Abdel-Wahab,Elisa de Stanchina,Neil H Segal, Luis A Diaz

Cancer cell (2025)

引用0浏览0WOS引用

A Phase Ia Study of the MEK1/2 Inhibitor PD-0325901 with the C-Met Inhibitor Crizotinib in Patients with Advanced Solid Cancers